메뉴 건너뛰기




Volumn 28, Issue 7, 2009, Pages 865-866

Systemic mastocytosis presenting as osteoporosis - A case report

Author keywords

Osteoporosis; Systemic mastocytosis

Indexed keywords

ALENDRONIC ACID; STEM CELL FACTOR RECEPTOR; TOLONIUM CHLORIDE; TRYPTASE;

EID: 67349137867     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1165-4     Document Type: Article
Times cited : (14)

References (7)
  • 1
    • 33745042240 scopus 로고    scopus 로고
    • Pathogenesis, clinical features, and treatment advances in mastocytosis
    • Pardanani A, Akin C, Valent P (2006) Pathogenesis, clinical features, and treatment advances in mastocytosis. Best Pract Res Clin Haematol 19(3):595-615
    • (2006) Best Pract Res Clin Haematol , vol.19 , Issue.3 , pp. 595-615
    • Pardanani, A.1    Akin, C.2    Valent, P.3
  • 2
    • 0035105585 scopus 로고    scopus 로고
    • Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis, A retrospective analysis of 158 cases
    • Delling G, Ritzel H, Werner M (2001) Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis, A retrospective analysis of 158 cases. Pathologe 22(2):132-140
    • (2001) Pathologe , vol.22 , Issue.2 , pp. 132-140
    • Delling, G.1    Ritzel, H.2    Werner, M.3
  • 3
    • 33746395041 scopus 로고    scopus 로고
    • The role of mast cells in osteoporosis
    • Chiappetta N, Gruber B (2006) The role of mast cells in osteoporosis. Semin Arthritis Rheum 36(1):32-36
    • (2006) Semin Arthritis Rheum , vol.36 , Issue.1 , pp. 32-36
    • Chiappetta, N.1    Gruber, B.2
  • 4
    • 0030827721 scopus 로고    scopus 로고
    • H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: Evidence obtained by using receptor antagonists in a rat synchronized resorption model
    • (Oct)
    • Dobigny C, Saffar JL (1997 Oct) H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: Evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 173(1):10-18
    • (1997) J Cell Physiol , vol.173 , Issue.1 , pp. 10-18
    • Dobigny, C.1    Saffar, J.L.2
  • 5
    • 52449085884 scopus 로고    scopus 로고
    • Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis
    • Verstovsek S, Tefferi A, Cortes J et al (2008) Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 14:3906-3915
    • (2008) Clin Cancer Res , vol.14 , pp. 3906-3915
    • Verstovsek, S.1    Tefferi, A.2    Cortes, J.3
  • 6
    • 19544379538 scopus 로고    scopus 로고
    • Systemic mastocytosis: A rare cause of osteoporosis and its response to bisphosphonate treatment
    • Lim AYN, Ostor AJK, Love S, Crisp AJ (2005) Systemic mastocytosis: A rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 64:965-966
    • (2005) Ann Rheum Dis , vol.64 , pp. 965-966
    • Lim, A.Y.N.1    Ostor, A.J.K.2    Love, S.3    Crisp, A.J.4
  • 7
    • 0029796701 scopus 로고    scopus 로고
    • Severe osteoporosis due to systemic mast cell disease: Successful treatment with Interferon alpha 2B
    • Lehman T, Beyeler C (1996) Severe osteoporosis due to systemic mast cell disease: Successful treatment with Interferon alpha 2B. Br J Rheumatol 35:898-900
    • (1996) Br J Rheumatol , vol.35 , pp. 898-900
    • Lehman, T.1    Beyeler, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.